Bullfrog AI Holdings, Inc. (BFRG)
NASDAQ: BFRG · Real-Time Price · USD
1.520
-0.160 (-9.52%)
Apr 1, 2026, 12:53 PM EDT - Market open
Bullfrog AI Revenue
In the year 2025, Bullfrog AI had annual revenue of $116.67K.
Revenue (ttm)
$116.67K
Revenue Growth
n/a
P/S Ratio
182.36
Revenue / Employee
$6,863
Employees
17
Market Cap
19.25M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 116.67K | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 65.00K | 55.00K | 550.00% |
| Dec 31, 2022 | 10.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Health Catalyst | 311.14M |
| American Well | 249.33M |
| OptimizeRx | 109.43M |
| Forian | 30.26M |
| DarioHealth | 22.36M |
| VSee Health | 14.43M |
| Zhongchao | 13.12M |
| OneMedNet | 1.36M |
BFRG News
- 1 day ago - BullFrog AI Shares Surge On Deal With Top Pharma Company For MDD Drug Targets - Benzinga
- 1 day ago - Bullfrog AI stock offers a rare opportunity for investors to take profit - Invezz
- 2 days ago - Dow Gains 200 Points; Bullfrog AI Shares Jump - Benzinga
- 2 days ago - BullFrog AI Announces Commercial Agreement with Top 5 Global Pharmaceutical Company to Identify and Prioritize Therapeutic Target in Major Depressive Disorder - GlobeNewsWire
- 7 days ago - BullFrog AI Unveils bfARENAS™ Scenario-based Decision Engine - GlobeNewsWire
- 21 days ago - BullFrog to Host Webinar on New Precision AI Capability - GlobeNewsWire
- 2 months ago - BullFrog AI to Unveil New Precision AI Capability - GlobeNewsWire
- 3 months ago - BullFrog AI-Driven Precision Oncology Analytics Identifies 3x Increase in Overall Survivability in Patient Subgroups through Key Biomarkers in Pancreatic Cancer - GlobeNewsWire